Karen Knudsen: Ned brings unparalleled expertise to ACS

Karen Knudsen shared a post by the American Cancer Society on LinkedIn:

“This year, four brilliant minds will join the American Cancer Society Board, including past National Cancer Institute (NCI) Director, acting FDA Commissioner, and UNC Lineberger Comprehensive Cancer Center Director Dr. Norman Sharpless. Ned brings unparalleled expertise to ACS as we work through advocacy, discovery, and patient support to end cancer as we know it!”

Quoting the American Cancer Society’s post:

“We are pleased to welcome Norman Sharpless, a distinguished figure in cancer research and policy. As the professor at UNC School of Medicine, former NCI director, and FDA commissioner, his commitment to advancing oncology is truly inspiring. Welcome, Dr. Sharpless!”

Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.